926 related articles for article (PubMed ID: 6471809)
21. Effect of increased glomerular permeability on the localization of immune aggregates and protamine-heparin aggregates in the rat.
Weening JJ; Grond J; Hoedemaeker PJ
Lab Invest; 1983 Nov; 49(5):619-25. PubMed ID: 6632777
[TBL] [Abstract][Full Text] [Related]
22. Renal apolipoproteins in nephrotic rats.
van Goor H; van der Horst ML; Atmosoerodjo J; Joles JA; van Tol A; Grond J
Am J Pathol; 1993 Jun; 142(6):1804-12. PubMed ID: 8506949
[TBL] [Abstract][Full Text] [Related]
23. Exacerbation of chronic aminonucleoside nephrosis by dietary cholesterol supplementation.
Diamond JR; Karnovsky MJ
Kidney Int; 1987 Nov; 32(5):671-7. PubMed ID: 3430956
[TBL] [Abstract][Full Text] [Related]
24. Effect of a low-protein diet on expression of non-muscle type myosin heavy-chain isoforms in glomeruli of rats with puromycin aminonucleoside nephrosis.
Koide H; Nakamura T; Kimura K; Ebihara I; Nagai R; Tomino Y
Nephrol Dial Transplant; 1996 Sep; 11(9):1769-74. PubMed ID: 8918620
[TBL] [Abstract][Full Text] [Related]
25. Focal glomerular hyalinosis and sclerosis in aminonucleoside and adriamycin nephrosis: pathogenetic and therapeutic considerations.
Elema JD; Weening JJ; Grond J
Contrib Nephrol; 1988; 60():73-82. PubMed ID: 3278860
[No Abstract] [Full Text] [Related]
26. Temocapril, a long-acting non-SH group angiotensin converting enzyme inhibitor, modulates glomerular injury in chronic puromycin aminonucleoside nephrosis.
Zheng Y; Shirato I; Maeda A; Kobayashi N; Liao J; Shou I; Fukui M; Tomino Y
J Nephrol; 2002; 15(1):36-41. PubMed ID: 11936424
[TBL] [Abstract][Full Text] [Related]
27. Nonanticoagulant protective effect of heparin in chronic aminonucleoside nephrosis.
Diamond JR; Karnovsky MJ
Ren Physiol; 1986; 9(6):366-74. PubMed ID: 3602582
[TBL] [Abstract][Full Text] [Related]
28. Incorporation of 35sulfate into the glomerular basement membrane in puromycin aminonucleoside nephrosis.
Garin EH; Boggs KP; Burke FC
Int J Pediatr Nephrol; 1985; 6(2):117-20. PubMed ID: 4030221
[TBL] [Abstract][Full Text] [Related]
29. Renal extracellular matrix accumulation in acute puromycin aminonucleoside nephrosis in rats.
Jones CL; Buch S; Post M; McCulloch L; Liu E; Eddy AA
Am J Pathol; 1992 Dec; 141(6):1381-96. PubMed ID: 1281619
[TBL] [Abstract][Full Text] [Related]
30. Altered expression of NDST-1 messenger RNA in puromycin aminonucleoside nephrosis.
Nakayama K; Natori Y; Sato T; Kimura T; Sugiura A; Sato H; Saito T; Ito S; Natori Y
J Lab Clin Med; 2004 Feb; 143(2):106-14. PubMed ID: 14966466
[TBL] [Abstract][Full Text] [Related]
31. Cyclosporin reduces proteinuria in rats with aminonucleoside nephrosis.
Kokui K; Yoshikawa N; Nakamura H; Itoh H
J Pathol; 1992 Mar; 166(3):297-301. PubMed ID: 1517884
[TBL] [Abstract][Full Text] [Related]
32. Laminin in glomerular basement membranes of aminonucleoside nephrotic rats. Increased proteinuria induced by antilaminin immunoglobulin G.
Abrahamson DR; Hein A; Caulfield JP
Lab Invest; 1983 Jul; 49(1):38-47. PubMed ID: 6865329
[TBL] [Abstract][Full Text] [Related]
33. Age-related nephropathy and proteinuria in rats with intact kidneys exposed to diets with different protein content.
Bertani T; Zoja C; Abbate M; Rossini M; Remuzzi G
Lab Invest; 1989 Feb; 60(2):196-204. PubMed ID: 2915514
[TBL] [Abstract][Full Text] [Related]
34. [Study on correlation between aminonucleoside induced experimental focal glomerular sclerosis and mesangial dysfunction in rats (author's transl)].
Sawaguchi H
Nihon Jinzo Gakkai Shi; 1982 Feb; 24(2):109-24. PubMed ID: 7098139
[No Abstract] [Full Text] [Related]
35. Alterations in proteoglycan metabolism in the nephrotic syndrome induced by the aminonucleoside of puromycin.
Klein DJ; Dehnel PJ; Oegema TR; Brown DM
Lab Invest; 1984 May; 50(5):543-51. PubMed ID: 6232422
[TBL] [Abstract][Full Text] [Related]
36. Glomerular sclerosis in Wistar rats: analysis of its variable occurrence after unilateral nephrectomy.
Grond J; van Goor H; Erkelens DW; Elema JD
Br J Exp Pathol; 1986 Aug; 67(4):473-9. PubMed ID: 3741773
[TBL] [Abstract][Full Text] [Related]
37. Cytotoxicity of sera from rats with puromycin aminonucleoside nephrosis.
Natori Y; Igawa Y; Nakao N; Natori Y
Nephron; 1996; 73(2):258-63. PubMed ID: 8773353
[TBL] [Abstract][Full Text] [Related]
38. Glomerular sclerotic lesions in the rat. Histochemical analysis of their macromolecular and cellular composition.
Grond J; van Goor H; Erkelens DW; Elema JD
Virchows Arch B Cell Pathol Incl Mol Pathol; 1986; 51(6):521-34. PubMed ID: 2878525
[TBL] [Abstract][Full Text] [Related]
39. Podocyte architecture in puromycin aminonucleoside-treated rats administered tungsten or allopurinol.
Ricardo SD; Bertram JF; Ryan GB
Exp Nephrol; 1995; 3(5):270-9. PubMed ID: 7583048
[TBL] [Abstract][Full Text] [Related]
40. Different types of segmental sclerosing glomerular lesions in six experimental models of proteinuria.
Howie AJ; Kizaki T; Beaman M; Morland CM; Birtwistle RJ; Adu D; Michael J; Williams AJ; Walls J; Matsuyama M
J Pathol; 1989 Feb; 157(2):141-51. PubMed ID: 2921674
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
